Happy New Year!

In 2023, all of us will continue to work as one toward the realization of materials for regenerating kidney functions.
We will continue to make every effort to prepare for the PMDA consultation this month and for FDA approval.
We look forward to your continued support in the coming year.　　　　　

　　　　　　　　　　　　　　　　　　　　　　　　　Hiroshi Yagi, Representative Director Matrisurge, Inc.